Adicet Bio (ACET) Other Non-Current Assets (2018 - 2026)

Adicet Bio's Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets changed 0.1% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (changed 0.1% YoY), while the FY2025 annual figure was $76000.0, down 97.38% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $2.9 million, up from $76000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $2.9 million in Q4 2024, with the low at $76000.0 in Q4 2025.
• The 5-year median for Other Non-Current Assets is $1.1 million (2023), against an average of $1.4 million.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets soared 707.33% in 2022, then tumbled 97.38% in 2025.
• Adicet Bio's Other Non-Current Assets stood at $1.2 million in 2022, then declined by 24.36% to $916000.0 in 2023, then soared by 216.92% to $2.9 million in 2024, then sank by 97.38% to $76000.0 in 2025, then jumped by 3715.79% to $2.9 million in 2026.
• Business Quant data shows ACET's Other Non-Current Assets at $2.9 million in Q1 2026, $76000.0 in Q4 2025, and $110000.0 in Q3 2025.